Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2005
10/13/2005US20050227951 Verification of translation
10/13/2005US20050227923 Stimulation of bone growth with thrombin peptide derivatives
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227280 Proteases
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050226884 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226874 Point mutations; immunology
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226859 Peg-Modified Uricase
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005DE102004012921A1 New 7-butynyl-8-(3-amino-1-piperidinyl)xanthine derivatives useful as dipeptidyl peptidase IV inhibitors, e.g. for treating diabetes, arthritis, obesity and osteoporosis
10/13/2005CA2575740A1 Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2561732A1 Antibody drug
10/13/2005CA2561530A1 Therapeutic or prophylactic agent for arthritis
10/13/2005CA2561383A1 Prophylactic and/or therapeutic agents for chronic musculoskeletal pain
10/13/2005CA2561317A1 Bmp-3 propeptides and related methods
10/13/2005CA2559865A1 Preparation of a cell concentrate from a physiological solution
10/12/2005EP1584624A1 A full-length polynucleotide coding chicken type ii collagen and the use of it
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583553A2 Therapeutic use of modulators of notch
10/12/2005EP1583529A2 Amino acid phenoxy ethers
10/12/2005EP1583525A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1212106B1 Phospholipid-coated implants
10/12/2005EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha
10/12/2005EP1143949B1 19-nor-vitamin d3 compounds with calcemic activity
10/12/2005EP1105104B1 Extended release buccal bioadhesive tablet
10/12/2005EP0904094B1 Treatment of bone disorders with adrenomedullin
10/12/2005CN1681920A Modified ADMTS4 molecules and method of use thereof
10/12/2005CN1681843A Parathyroid hormone-like polypeptides
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681817A Biologically active compounds
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681776A Amino alcohol derivative, addition salt thereof, and immunosuppressant
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681516A Method for preventing or reducing secondary fractures after hip fracture
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE)
10/12/2005CN1680409A Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680259A Aspirin-triggered lipid mediators
10/12/2005CN1679956A Treatment of androgen-deprivation induced osteoporosis
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679923A Oral enteric-coated microsphere of Thymosin and preparation thereof
10/12/2005CN1679894A Chinese medicinal herb capsule for treating hyperosteogeny
10/12/2005CN1679881A Capsules for zhongtongling for bone fracture and soft tissue injury and their making method
10/12/2005CN1679877A Oral Chinese medicine preparation of caput femoris ischemic necrosis and production thereof
10/12/2005CN1679853A Medicine for treating internal bone wound
10/12/2005CN1679841A Powder injection of sarcandra and its making method
10/12/2005CN1679836A Sanhuang capsules and preparation thereof
10/12/2005CN1679792A Chinese medicinal soft capsule for treating hyperosteogeny and making method thereof
10/12/2005CN1679784A Chinese medicine preparation for treating wound, preparation and quality control thereof
10/12/2005CN1679782A Chinese medicine preparation for treating pain, preparation and quality control thereof
10/12/2005CN1679767A Medicine preparation for preventing osteoporosis and preparation thereof
10/12/2005CN1679765A Chinese medicine extract for preventing female involutional syndrome or osteoporosis
10/12/2005CN1679756A Delayed-releasing preparation for treating osteoporosis
10/12/2005CN1679743A Chinese medicine herb prescription for treating neuralgia and capital necrosis
10/12/2005CN1679735A Chinese medicinal herb composition for treating fracture
10/12/2005CN1679719A Compound zedoary oil oral preparation and production thereof
10/12/2005CN1679716A Medicine for treating low myeloproliferative diseases and its preparing method
10/12/2005CN1679695A Chinese medicine preparation for treating bone fracture and preparing method thereof
10/12/2005CN1679694A Compound pigenonpea Chinese medicine preparation and preparing method thereof
10/12/2005CN1679685A Osteopathy plaster and formulating method thereof
10/12/2005CN1679684A Rubber plaster for treating insufficient cold type chronic gstroentertis and rheumatic arthritis and preparation thereof
10/12/2005CN1679679A Chinese medicine composition and preparation thereof
10/12/2005CN1679634A Composition containing soybean isoflavone and use thereof
10/12/2005CN1679624A 磁药 Magnetic drug
10/12/2005CN1679622A Use of sodium selenite in preparing medicine for osseous arthritis
10/12/2005CN1679608A Compound preparation of inosine, triphosphoadenosine and vitamin C and use thereof
10/12/2005CN1679584A Medicine for treating osteomyelitis and preparation thereof
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679562A Antiviral compounds
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679552A Preferential inhibition of release of pro-inflammatory cytokines
10/12/2005CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222374C Extrusion die
10/12/2005CN1222303C Traditional Chinese medicine wine fore relaxing muscles and tendons and activating blood circulation, expelling wind and stopping pain, and relieving flatulence and relaxing the bowels
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953809 Monocyte chemoattractant protein-1 inhibitor compounds
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/11/2005US6953788 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/11/2005US6953784 Cross-linked polysaccharide drug carrier
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 820